Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coating Plasma Innovation is a French industrial technology company focused on atmospheric cold plasma surface treatment and plasma-enhanced coating of flexible materials. The company develops and operates roll-to-roll plasma equipment, process chemistries, and contract treatment services for applications in packaging, printing, textiles, electronics, filtration, release liners, aerospace, and selected medical or life-science materials markets. CPI is known for high-speed atmospheric plasma treatment, thin-film functionalization, and deposition processes used to modify surface properties such as adhesion, coating performance, and barrier characteristics. In June 2023, CPI and Europlasma were combined into the newly created Plasmalex group, and CPI now operates within that broader plasma technology organization. The business appears to be primarily an advanced materials and industrial coatings company rather than a biotech, pharma, or healthcare therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CPI Plasma.